While AMT-130 could result in meaningful revenue for ClearPoint, the Huntington's opportunity is relatively modest compared ...

Universities must do more to provide students with cell and gene therapy manufacturing skills, according to a new study.

Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver 6 presentations offering insights into the research and development of ...

French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...

Treatment introduces an expansion of the scope of gene therapies that might lead to similar treatments for neurodegenerative ...

A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...

From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and ...

D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...

Life sciences ranked among the top four sectors, with a notable rise of companies integrating AI and biotech in ...

Genome editing is increasingly recognised as a leading frontier in biomedical research and an essential driver of healthcare ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...